TREATMENT REGIMENS USED IN HIV-ASSOCIATED PULMONARY TUBERCULOSIS AND THEIR SAFETY PROFILE
Description
Anti-tuberculosis, antiretroviral, and adjunct pathogenetic treatment regimens, together with their adverse effects, were analyzed in 79 patients with tuberculosis (n=41) and tuberculosis-HIV coinfection (n=38). An IDV-based antiretroviral regimen was absolutely predominant in the coinfection group (86.8%) and was not used at all in the isolated HIV group (P<0.001). Adjunct pathogenetic therapy and adverse effects (allergic reactions, loss of appetite, vomiting) were statistically significantly more frequent in the coinfection group, confirming that coinfection increases the overall treatment burden.
Keywords: anti-tuberculosis therapy, antiretroviral therapy, second-line drugs, adverse effects, treatment regimen.